Septerna (SEPN) Shares Outstanding (Diluted Average) (2023 - 2026)
Septerna's quarterly Shares Outstanding (Diluted Average) came in at $44.8 million in Q1 2026, up 1.87% year-on-year from $43.9 million in Q1 2025, and up 1.34% quarter-over-quarter from $44.2 million in Q2 2025.
Septerna has reported Shares Outstanding (Diluted Average) for 4 years, with the latest figure at $44.8 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | 44.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.76 Mn |
| Jun 30, 2025 | 44.17 Mn |
| Mar 31, 2025 | 43.94 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | 2.28 Mn |
| Mar 31, 2024 | 2.23 Mn |
| Sep 30, 2023 | 1.86 Mn |